Literature DB >> 5788167

2-chloroadenosine 5'-phosphate and 2-chloroadenosine 5'-diphosphate, pharmacologically active nucleotide analogs.

G Gough, M H Maguire, F Michal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5788167     DOI： 10.1021/jm00303a604

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  6 in total

1.  Effects of the 3',5'-cyclic phosphates of 2-methylthioadenosine, 2-chloroadenosine and adenosine on platelet aggregation.

Authors:  M H Maguire; F Penglis-Caredes; G R Gough
Journal:  Experientia       Date:  1974-08-15

Review 2.  Characteristics of an ADP receptor mediating platelet activation.

Authors:  R W Colman; W R Figures
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

3.  Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.

Authors:  N J Cusack; S M Hourani
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

4.  Studies on the coronary dilator actions of some adenosine analogues.

Authors:  L B Cobbin; R Einstein; M H Maguire
Journal:  Br J Pharmacol       Date:  1974-01       Impact factor: 8.739

5.  Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.

Authors:  N J Cusack; S M Hourani
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

Review 6.  Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy.

Authors:  Nina Wolska; Marcin Rozalski
Journal:  Int J Mol Sci       Date:  2019-11-03       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.